Price $61.05 |
Market Cap
4.52B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
20.9
|
P/B
31.03
|
P/S
6.06
|
Dividend %
-
|
|
P/CF
37.1
|
P/FCF
16.9
|
Op. Cash Flow
305.9K
|
FCF
2.1
|
|
Op. Margin
39.20%
|
Net Margin
30.20%
|
ROE
193.30%
|
ROI
13.00%
|
|
ROA
13.00%
|
EPS Growth
-33.20%
|
Current Ratio
5.6
|
Debt/Equity
879.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
